896 related articles for article (PubMed ID: 10160337)
21. Blood issues update: minimizing the risk of transfusion-associated HIV infection. American Hospital Association Technical Advisory Task Force on Blood Resources.
Hosp Technol Ser; 1989 Aug; 8(21):1-14. PubMed ID: 10314380
[TBL] [Abstract][Full Text] [Related]
22. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
Lackritz EM
AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
[TBL] [Abstract][Full Text] [Related]
23. [HIV retrospective study of the German Red Cross blood donation service in Germany].
Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B
Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915
[TBL] [Abstract][Full Text] [Related]
24. Update: HIV-2 infection among blood and plasma donors--United States, June 1992-June 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Aug; 44(32):603-6. PubMed ID: 7630339
[TBL] [Abstract][Full Text] [Related]
25. Cardiac pacemaker registry--FDA, HCFA. Final rule.
Fed Regist; 1987 Jul; 52(141):27756-65. PubMed ID: 10301665
[TBL] [Abstract][Full Text] [Related]
26. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 2000 Dec; 65(239):77497-9. PubMed ID: 11503726
[TBL] [Abstract][Full Text] [Related]
27. HIV transmission through transfusion --- Missouri and Colorado, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(41):1335-9. PubMed ID: 20966896
[TBL] [Abstract][Full Text] [Related]
28. Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion.
Menache D; O'Malley JP
Biologicals; 1996 Sep; 24(3):277-83. PubMed ID: 8978926
[TBL] [Abstract][Full Text] [Related]
29. Progress toward strengthening blood transfusion services--14 countries, 2003-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(47):1273-7. PubMed ID: 19037194
[TBL] [Abstract][Full Text] [Related]
30. Update: HIV-2 infection among blood and plasma donors--United States, June 1992-June 1995.
Pediatr AIDS HIV Infect; 1995 Dec; 6(6):407-9. PubMed ID: 11361466
[TBL] [Abstract][Full Text] [Related]
31. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
Fed Regist; 1999 May; 64(93):26282-7. PubMed ID: 10558530
[TBL] [Abstract][Full Text] [Related]
32. Distribution of blood derivatives by registered blood establishments that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; delay of applicability date. Final rule; delay of applicability date.
Food and Drug Administration, HHS
Fed Regist; 2006 Nov; 71(218):66108-9. PubMed ID: 17099971
[TBL] [Abstract][Full Text] [Related]
33. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.
Lackritz EM; Satten GA; Aberle-Grasse J; Dodd RY; Raimondi VP; Janssen RS; Lewis WF; Notari EP; Petersen LR
N Engl J Med; 1995 Dec; 333(26):1721-5. PubMed ID: 7491134
[TBL] [Abstract][Full Text] [Related]
34. Safe blood: the WHO sets out its principles.
Koistinen J
AIDS Anal Afr; 1992; 2(6):4, 6. PubMed ID: 12344630
[TBL] [Abstract][Full Text] [Related]
35. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
Zeiler T; Kretschmer V; Sibrowski W
Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
[TBL] [Abstract][Full Text] [Related]
36. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human); companion document to direct final rule. Food and Drug Administration, HHS. Proposed rule.
Fed Regist; 1999 May; 64(93):26344-8. PubMed ID: 10558531
[TBL] [Abstract][Full Text] [Related]
37. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
38. Blood Donor Locator Service--Social Security Administration. Final rules.
Fed Regist; 1991 Dec; 56(247):66561-6. PubMed ID: 10116070
[TBL] [Abstract][Full Text] [Related]
39. Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.
Fed Regist; 1981 Nov; 46(226):57480-1. PubMed ID: 10253366
[TBL] [Abstract][Full Text] [Related]
40. Risk of HIV infection from blood transfusion in Montreal.
Remis RS; Delage G; Palmer RW
CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
